Display options
Cite
Zubcevic J, Waki H, Diez-Freire C, et al. Chronic blockade of phosphatidylinositol 3-kinase in the nucleus tractus solitarii is prohypertensive in the spontaneously hypertensive rat. Hypertension. 2008;53(1):97-103doi: 10.1161/HYPERTENSIONAHA.108.122341.
Zubcevic, J., Waki, H., Diez-Freire, C., Gampel, A., Raizada, M. K., & Paton, J. F. (2009). Chronic blockade of phosphatidylinositol 3-kinase in the nucleus tractus solitarii is prohypertensive in the spontaneously hypertensive rat. Hypertension (Dallas, Tex. : 1979), 53(1), 97-103. https://doi.org/10.1161/HYPERTENSIONAHA.108.122341
Zubcevic, Jasenka, et al. "Chronic blockade of phosphatidylinositol 3-kinase in the nucleus tractus solitarii is prohypertensive in the spontaneously hypertensive rat." Hypertension (Dallas, Tex. : 1979) vol. 53,1 (2009): 97-103. doi: https://doi.org/10.1161/HYPERTENSIONAHA.108.122341
Zubcevic J, Waki H, Diez-Freire C, Gampel A, Raizada MK, Paton JF. Chronic blockade of phosphatidylinositol 3-kinase in the nucleus tractus solitarii is prohypertensive in the spontaneously hypertensive rat. Hypertension. 2009 Jan;53(1):97-103. doi: 10.1161/HYPERTENSIONAHA.108.122341. Epub 2008 Nov 17. PMID: 19015400; PMCID: PMC2735392.
Copy Download .nbib Format: NLM
Share it on

Hypertension. 2009 Jan;53(1):97-103. doi: 10.1161/HYPERTENSIONAHA.108.122341. Epub 2008 Nov 17.

Chronic blockade of phosphatidylinositol 3-kinase in the nucleus tractus solitarii is prohypertensive in the spontaneously hypertensive rat.

Hypertension (Dallas, Tex. : 1979)

Jasenka Zubcevic, Hidefumi Waki, Carlos Diez-Freire, Alexandra Gampel, Mohan K Raizada, Julian F R Paton

Affiliations

  1. Department of Physiology and Pharmacology, Bristol Heart Institute, School of Medical Sciences, University of Bristol, Bristol, BS8 1TD, United Kingdom.

PMID: 19015400 PMCID: PMC2735392 DOI: 10.1161/HYPERTENSIONAHA.108.122341

Abstract

Phosphatidylinositol 3-kinase (PI3K) within brain stem neurons has been implicated in hypertension in the spontaneously hypertensive rat (SHR). Previously, we demonstrated elevated expression of PI3K subunits in rostral ventrolateral medulla and paraventricular nucleus of SHRs compared with Wistar-Kyoto rats. Here, we considered expression levels of PI3K in the nucleus tractus solitarii, a pivotal region in reflex regulation of arterial pressure, and determined its functional role for arterial pressure homeostasis in SHRs and Wistar-Kyoto rats. We found elevated mRNA levels of p110beta and p110delta catalytic PI3K subunits in the nucleus tractus solitarii of adult (12 to 14 weeks old) SHRs relative to the age-matched Wistar-Kyoto rats (fold differences relative to beta-actin: 1.7+/-0.2 versus 1.01+/-0.08 for p110beta, n=6, P<0.05; 1.62+/-0.15 versus 1.02+/-0.1 for p110delta, n=6, P<0.05). After chronic blockade of PI3K signaling in the nucleus tractus solitarii by lentiviral-mediated expression of a mutant form of p85alpha, systolic pressure increased from 175+/-3 mm Hg to 191+/-6 mm Hg (P<0.01) in SHRs but not in Wistar-Kyoto rats. In addition, heart rate increased (from 331+/-6 to 342+/-6 bpm; P<0.05) and spontaneous baroreflex gain decreased (from 0.7+/-0.07 to 0.5+/-0.04 ms/mm Hg; P<0.001) in the SHRs. Thus, PI3K signaling in the nucleus tractus solitarii of SHR restrains arterial pressure in this animal model of neurogenic hypertension.

References

  1. Hypertension. 2002 Feb;39(2 Pt 2):656-61 - PubMed
  2. Brain Res. 1985 Jul 8;338(1):169-72 - PubMed
  3. Can J Cardiol. 2000 Sep;16(9):1137-46 - PubMed
  4. Curr Hypertens Rep. 2002 Apr;4(2):129-35 - PubMed
  5. Hypertension. 1981 Jan-Feb;3(1):48-52 - PubMed
  6. Oncogene. 2005 Nov 14;24(50):7435-42 - PubMed
  7. Hypertension. 2001 Nov;38(5):1087-92 - PubMed
  8. Curr Hypertens Rep. 2006 Jun;8(3):249-54 - PubMed
  9. Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R625-33 - PubMed
  10. Circ Res. 2002 Aug 23;91(4):360-9 - PubMed
  11. EMBO J. 1994 May 15;13(10):2313-21 - PubMed
  12. Circ Res. 1980 Jun;46(6):842-53 - PubMed
  13. Adv Drug Deliv Rev. 2005 Jan 2;57(1):79-93 - PubMed
  14. Circ Res. 1973 May;32(5):584-93 - PubMed
  15. Hypertension. 2007 Jun;49(6):1321-7 - PubMed
  16. Exp Physiol. 2006 Jan;91(1):201-13 - PubMed
  17. Hypertension. 1989 Aug;14(2):177-83 - PubMed
  18. Hypertension. 2006 Oct;48(4):644-50 - PubMed
  19. Clin Sci (Lond). 1982 Jun;62(6):589-94 - PubMed
  20. J Comp Neurol. 2000 Feb 7;417(2):233-49 - PubMed
  21. Brain Res. 1983 Oct 24;277(1):31-40 - PubMed
  22. Cardiovasc Res. 2007 Oct 1;76(1):184-93 - PubMed
  23. Am J Physiol. 1994 May;266(5 Pt 2):H1993-2000 - PubMed
  24. Brain Res. 1981 Jul 27;217(1):186-91 - PubMed
  25. Prog Brain Res. 1977;47:169-88 - PubMed
  26. Am J Physiol. 1991 Oct;261(4 Pt 2):H1292-9 - PubMed
  27. Clin Exp Pharmacol Physiol. 1988 Apr;15(4):289-92 - PubMed
  28. Hypertension. 1998 Jan;31(1):68-72 - PubMed
  29. Tohoku J Exp Med. 1990 May;161(1):55-64 - PubMed
  30. Clin Exp Pharmacol Physiol. 1992 Aug;19(8):587-97 - PubMed
  31. Hypertension. 1980 Mar-Apr;2(2):228-35 - PubMed
  32. Methods. 2001 Dec;25(4):402-8 - PubMed
  33. Neurosci Lett. 1988 Jun 29;89(2):152-5 - PubMed
  34. Trends Cardiovasc Med. 2003 Apr;13(3):93-101 - PubMed
  35. J Auton Pharmacol. 1996 Apr;16(2):69-77 - PubMed
  36. J Physiol. 2003 Jan 1;546(Pt 1):233-42 - PubMed
  37. J Neurosci. 1999 Apr 1;19(7):2413-23 - PubMed
  38. J Hypertens. 2002 Sep;20(9):1675-88 - PubMed
  39. Hypertens Res. 2008 Jun;31(6):1209-18 - PubMed
  40. Circ Res. 1986 Aug;59(2):178-93 - PubMed
  41. Neurosci Lett. 1983 Mar 28;36(1):37-42 - PubMed
  42. Hypertension. 2007 Sep;50(3):537-42 - PubMed
  43. Circulation. 2000 Jan 25;101(3):329-35 - PubMed
  44. Cell Mol Life Sci. 2008 Jan;65(1):113-27 - PubMed
  45. Circ Res. 2005 Feb 18;96(3):277-9 - PubMed
  46. J Neurophysiol. 2003 Nov;90(5):3155-60 - PubMed
  47. Nat Protoc. 2006;1(2):581-5 - PubMed
  48. Physiol Genomics. 2003 Feb 06;12(3):221-8 - PubMed
  49. Auton Neurosci. 2006 Jul 30;128(1-2):48-52 - PubMed
  50. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed

Substances

MeSH terms

Publication Types

Grant support